Clinical Trials Browser

Withdrawn × Interventional × zimberelimab × Clear all

Triple Negative Breast Neoplasms

NCT07283848 2025-12-26

Zimberelimab + Domvanalimab in Gastroesophageal Adenocarcinoma

Phase 2 Withdrawn

Gastrointestinal

Stomach Neoplasms

NCT04892875 2023-11-30

PANTHEoN

Phase 1 Withdrawn

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms, Pharyngeal Neoplasms

Clinical Trials

ADJUNCT

Zimberelimab + Domvanalimab in Gastroesophageal Adenocarcinoma

PANTHEoN